Quick Answer
iSpecimen Inc. reported Stockholders Equity of $3.31 million for fiscal year 2024.
iSpecimen Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | $3.31M | -66.0% |
| 2023 | $9.74M | -52.0% |
| 2022 | $20.31M | -31.8% |
| 2021 | $29.79M | +209.2% |
| 2020 | -$27.28M | -20.1% |
| 2019 | -$22.72M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.07M | -34.8% | +394.0% |
| June 30, 2025 | $622.0K | -89.8% | -62.7% |
| March 31, 2025 | $1.67M | -75.5% | -49.6% |
| December 31, 2024 | $3.31M | -66.0% | -29.8% |
| September 30, 2024 | $4.71M | -62.9% | -22.6% |
| June 30, 2024 | $6.09M | -58.6% | -10.6% |
| March 31, 2024 | $6.81M | -62.3% | -30.1% |
| December 31, 2023 | $9.74M | -52.0% | -23.3% |
- iSpecimen Inc. showed a decrease of -66.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2024 period, iSpecimen Inc.’s stockholders equity has grown by 114.6% (from -$22.72 million to $3.31 million).
- The most recent figure is from iSpecimen Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 14, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: